Osteogenesis imperfecta (OI) is a skeletal disorder primarily caused by mutations in the type I collagen genes. However, recent investigations have revealed that mutations in the genes encoding for cartilage-associated protein (CRTAP) or prolyl 3-hydroxylase 1 (P3H1) can cause a severe, recessive form of OI. These reports show minimal 3-hydroxylation of key proline residues in type I collagen as a result of CRTAP or P3H1 deficiency and demonstrate the importance of P3H1 and CRTAP to bone structure and development. P3H1 and CRTAP have previously been shown to form a stable complex with cyclophilin B, and P3H1 was shown to catalyze the 3-hydroxylation of specific proline residues in procollagen I in vitro. Here we describe a mouse model in which the P3H1 gene has been inactivated. Our data demonstrate abnormalities in collagen fibril ultrastructure in tendons from P3H1 null mice by electron microscopy. Differences are also seen in skin architecture, as well as in developing limbs by histology. Additionally bone mass and strength were significantly lower in the P3H1 mice as compared with wild-type littermates. Altogether these investigations demonstrate disturbances of collagen fiber architecture in tissues rich in fibrillar collagen, including bone, tendon, and skin. This model system presents a good opportunity to study the underlying mechanisms of recessive OI and to better understand its effects in humans.
Osteogenesis imperfecta (OI)2 is an autosomal dominant genetic disorder and is primarily caused by mutations in the genes encoding for type I collagen (COL1A1 and COL1A2). It is characterized as a heterogeneous group of conditions with varying degrees of severity, including bone fragility, low bone mass, susceptibility to fracture, short stature, bowing of the long bones, and moderate to severe kyphoscoliosis (1-3).Recessive OI cases have been reported more recently and have been shown to be caused by mutations in the cartilage-associated protein (CRTAP), prolyl 3-hydroxylase 1 or leprecan (LEPRE1) gene and cyclophilin B (CypB) (4 -9). The majority of these more recently described patients have been shown to have severe to lethal forms of autosomal recessive OI with some distinctive features (5-6, 10). The 3-hydroxylation of key residues in collagen I from these patients was significantly reduced indicating the importance of P3H1 and CRTAP in collagen stability, secretion, and ultimately in bone development. Additionally, the importance of CRTAP in bone development was demonstrated in CRTAP knock-out mice, which show osteochondrodysplasia characterized by severe osteoporosis and decreased osteoid production (4). The CypB knock-out mouse also shows severe OI (11). P3H1 has been shown to be responsible for the modification of the proline into 3(S)-hydroxyproline in the Xaa position of the Gly-Xaa-Yaa repeating sequence of the alpha 1 chain of type I procollagen (12). It is likely that this enzyme also catalyzes modifications in types II and III collagen as well, although this has not yet been shown (13). P3H1 e...